Biotest Aktiengesellschaft (BIO3) — Financial Flexibility Index
Biotest Aktiengesellschaft (BIO3) has a Financial Flexibility Index of -0.06x as of March 2025. Free cash flow of €-58.10 Million (operating CF €-58.10 Million minus capex €0.00) represents 0% of total liabilities (€906.90 Million). Check BIO3 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biotest Aktiengesellschaft Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for Biotest Aktiengesellschaft across 23 annual periods. For the full cash flow conversion analysis, see BIO3 cash generation efficiency.
Annual Financial Flexibility Index for Biotest Aktiengesellschaft (2002–2024)
Year-by-year free cash flow to debt coverage for Biotest Aktiengesellschaft. Explore Biotest Aktiengesellschaft cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.10x | €89.60 Million | €60.90 Million | €903.30 Million | ▲ +194.7% |
| 2023 | 0.03x | €30.70 Million | €-2.70 Million | €912.00 Million | ▲ +350.0% |
| 2022 | -0.01x | €-11.20 Million | €-40.50 Million | €831.90 Million | ▼ -118.7% |
| 2021 | 0.07x | €52.10 Million | €33.90 Million | €723.80 Million | ▲ +382.0% |
| 2020 | 0.01x | €10.30 Million | €-16.70 Million | €689.70 Million | ▲ +1786.2% |
| 2019 | 0.00x | €500.00K | €-33.60 Million | €631.50 Million | ▼ -90.6% |
| 2018 | 0.01x | €4.60 Million | €-50.00 Million | €547.10 Million | ▼ -96.2% |
| 2017 | 0.22x | €140.80 Million | €34.30 Million | €630.70 Million | ▼ -39.1% |
| 2016 | 0.37x | €209.80 Million | €65.90 Million | €572.10 Million | ▲ +45.4% |
| 2015 | 0.25x | €138.80 Million | €38.10 Million | €550.40 Million | ▲ +318.3% |
| 2014 | 0.06x | €33.30 Million | €-11.40 Million | €552.40 Million | ▼ -28.1% |
| 2013 | 0.08x | €35.70 Million | €-7.20 Million | €425.80 Million | ▼ -62.1% |
| 2012 | 0.22x | €69.23 Million | €34.73 Million | €312.91 Million | ▼ -24.9% |
| 2011 | 0.29x | €98.99 Million | €72.28 Million | €336.09 Million | ▼ -10.8% |
| 2010 | 0.33x | €107.20 Million | €77.83 Million | €324.73 Million | ▲ +67.1% |
| 2009 | 0.20x | €71.85 Million | €31.68 Million | €363.59 Million | ▼ -5.8% |
| 2008 | 0.21x | €71.03 Million | €34.49 Million | €338.67 Million | ▲ +100.6% |
| 2007 | 0.10x | €32.51 Million | €32.51 Million | €310.94 Million | ▼ -22.6% |
| 2006 | 0.14x | €26.31 Million | €26.31 Million | €194.69 Million | ▼ -5.5% |
| 2005 | 0.14x | €28.32 Million | €28.32 Million | €198.12 Million | ▼ -18.5% |
| 2004 | 0.18x | €43.91 Million | €25.29 Million | €250.31 Million | ▲ +16.9% |
| 2003 | 0.15x | €37.03 Million | €16.52 Million | €246.69 Million | ▲ +17.9% |
| 2002 | 0.13x | €33.26 Million | €2.46 Million | €261.20 Million | — |